Recent studies showed that the upregulation of dopamine D2 receptor (DRD2) in reactive astrocytes in the brains of MS patients [30], and the dysregulation of the dopaminergic system causes psychiatric symptoms in these patients [31]. Here, DRD2 is linked to myeloid sarcoma.